lorem ipsum dolor sit

Focused on solving unmet needs in ophthalmology

Our pipeline of topical drug candidates promises improvement in drug delivery for the back- and front-of-the-eye

lorem ipsum dolor sit

Changing the paradigm in DME

Developing non-invasive therapy for DME, a leading cause of blindness

lorem ipsum dolor sit

Taking a new approach in managing ocular inflammation

The potential of topical biologic for ophthalmic use

lorem ipsum dolor sit

Simplifying treatment for post-cataract surgery inflammation

The potential for fewer daily drops and improved compliance

lorem ipsum dolor sit

Disruptive new technologies for ophthalmic topical treatment

Enabling new topical options for patients with eye diseases